The cruciate ligament repair procedures market size is estimated to be USD XX.XX million in 2020 and is projected to register a CAGR of X.X% to reach USD 19,192.8 million by 2028. But due to the COVID-19 impact, market size estimation is down to USD XX.XX million in 2020 and is projected to register a CAGR of X.X % to hit USD 18,598.0 million by 2028.
A ligament is a band of tissue that holds the bones together. The knee ligaments help keep the knee stable. These ligaments are specifically classified into cruciate ligament and collateral ligament. Various factors such as a rise in the number of knee reconstruction procedures, an increase in ageing population, coupled with an increase in the incidence of age-related diseases such as rheumatoid arthritis and osteoarthritis and an increase in government assistance, have continued to contribute to the growth of the global cruciate ligament repair procedures market.
Sports activities are the leading cause of knee ligament injuries worldwide. Athletes are more likely to undergo ACL injuries, which hinder their flexibility and mobility. According to an emergency room visit survey performed by Safe Kids Worldwide, more than a million young athletes visit hospitals for sports-related injuries worldwide every year. In addition, according to data published by Michigan State University, about 46% of all knee injuries are attributed to soccer, followed by basketball (42%), running (38%), and gymnastics (31%).
The global cruciate ligament repair procedures market report has been segmented into procedure type, indication, and region.
Procedure Type Outlook
Based on the procedure type, the market is classified into posterior cruciate ligament (PCL) repair and anterior cruciate ligament (ACL) repair. Among these, the posterior cruciate ligament (PCL) repair market segment is holding the largest market share in 2020. The growing incidence of vehicular accidents, along with sports injuries, is the major factor in driving the PCL repair segment. However, during the forecast period, the anterior cruciate ligament (ACL) repair segment is expected to witness the fastest growth. This can be attributed to a growing number of ACL injuries and increased participation in physical activities.
Based on indication, the market is classified into trauma, arthritis, and others. Among these, the trauma market segment is holding the largest market share in 2020. An ACL or PCL tear is often caused by high trauma events like car accidents. One of the main factors in driving the segment’s growth is rising injuries due to road accidents worldwide.
By region, the global cruciate ligament repair procedures market is segmented as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The North America region is anticipated to account for the largest share in 2020 due to rising healthcare expenditure and investments for developing healthcare infrastructure. Moreover, the majority of the key players are headquartered in the U.S., which provides a wide market for cruciate ligament repair procedures.
By procedure type
- Posterior Cruciate Ligament (PCL) Repair
- Anterior Cruciate Ligament (ACL) Repair
- Others (Sports injuries, Day to day life injuries)
Regions covered in the report:
- South Korea
- Rest of the Asia Pacific
- The Netherlands
- Rest of the Europe
Middle East & Africa:
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Rest of South America
The company analysis section encompasses the competitive scenario in the market providing a detailed analysis of the market. This helps understand the types of products and solutions offered by the companies in the market across the target application areas. In addition, it highlights the nature of strategies adopted by the market players with regards to a particular product/solution, application, and region to sustain/penetrate the given market
Major Companies Covered in the report:
- ZIMMER BIOMET HOLDINGS, INC.
- Smith & Nephew PLC
- Arthrex, Inc.
- Stryker Corporation
- Tissue Regenix Group PLC
- Integra LifeSciences Holding Corporation
- Medtronic PLC
- Parcus Medical, LLC
- CONMED Corporation
- Wright Medical N.V.
- Johnson & Johnson
- Lifenet Health
- MTF Biologics
- RTI Surgical, Inc.
February 2019 - Colfax Corporation invested $3.15 billion in the acquisition of DJO Global, Inc., a leading diversified technology business. The acquisition is the next inevitable step in making companies less cyclical and implementing a value-compounding growth strategy by offering stable, increasing cash flows.
MARCH 2018 - Biorez, Inc. made an investment of $1.5 million, after positive results from animal testing of its latest anterior cruciate ligament (ACL) repair implant. It uses a patented tissue-engineered scaffold that stabilizes the knee, making it easier for the body to regrow new ACL tissue, and then resorbs it entirely, leaving only new functional tissue.
For more information, contact: [email protected]